mardi 12 mai 2020

Onco Actu du 12 mai 2020


1.1 BIOLOGIE - GÉNOME



Genetic Ancestry Linked to Differences in Molecular Features of Cancers [Genome Web]











4.15 DÉP., DIAG. & PRONO. - IMAGERIE



PSMA PET-CT Accurately Detects Prostate Cancer Spread, Trial Shows [NCI]










4.9 DÉP., DIAG. & PRONO. - SEIN



Advanced, Fatal Breast Cancers Reduced Through Mammography Screening [AJMC]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment [Hong Kong Baptist University]











5.12.1 IMMUNOTHÉRAPIES - PARTENARIATS



Bluebird nabs $200M in early payout from retooled Bristol Myers BCMA deal [Fierce Biotech]











bluebird bio Announces Amended BCMA CAR-T Collaboration Agreement [bluebird bio]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



Cancer-eating immune cells kitted out with CARs [Nature Biotechnology]











5.12.6 IMMUNOTHÉRAPIES - AMM



EMA Does Not Recommend Extending the Use of Pembrolizumab [ESMO]











5.2 PHARMA



AstraZeneca, Merck's star PARP inhibitor Lynparza expands reach in ovarian cancer with new US approval [EndPoints]











5.2.6 PHARMA - BIOTECH



Immunomedics raises $459M as Trodelvy breast cancer launch kicks off amid COVID-19 [Fierce Pharma]











5.4 TRAITEMENTS - ECONOMIE



NICE backs Roche's Kadcyla for HER2-positive early breast cancer [Pharma Times]











5.5.1.1 ASCO (GÉNÉRAL) - INDUSTRIELS



Bristol Myers Squibb Research at ASCO Demonstrates Diverse Approaches in Treating Cancer to Improve Outcomes for Patients [BMS]











6.1 OBSERVATION



Antihistamines may help patients with malignant melanoma [Lund University]











6.15 LUTTE CONTRE LES CANCERS - COVID-19



Lower Antibodies Rate in Cancer Patients After Symptomatic COVID-19 Than In Healthcare Workers [ESMO]










Decline in cancer diagnoses due to corona crisis of international interest [University of Twente]